1.
Product Overview
2.
Research Methodology
3.
Impact of COVID-19 on Global Senolytic Drugs Market
4.
Executive Summary
5.
Voice of Customer
5.1.
Preference, By Type
5.2.
Factors Contributing to Demand for Senolytic Drugs
5.3.
Barriers to Adoption of Senolytic Drugs
5.4.
Brand Awareness
6.
Clinical Trials
6.1.
Ongoing Clinical Trials
6.2.
Completed Clinical Trials
6.3.
Terminated Clinical Trials
6.4.
Clinical Trial Analysis
7.
Patent Analysis
7.1.
Patent Granted (2016-2020)
7.2.
Patent Applications Filed
8. Global Senolytic
Drugs Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1. By Type (FOXO4-related peptides, bcl-2 Family Inhibitors,
Src Tyrosine Kinase Inhibitors, Navitoclax, Dasatinib & Quercetin, Others)
8.2.2. By Application (Longevity, Senescence Inhibition,
Cardiovascular Diseases, Neural Degenerative Diseases, Others)
8.2.3. By Distribution Channel (Retail Pharmacies, Hospital
Pharmacies, Online Pharmacies)
8.2.4.
By Company (2020)
8.2.5. By Region
8.3.
Product Market Map
9. North America
Senolytic Drugs Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
9.2.3. By Distribution Channel
9.2.4.
By Country
9.3.
North America: Country Analysis
9.3.1.
United States Senolytic Drugs Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type
9.3.1.2.2.
By Application
9.3.1.2.3.
By Distribution Channel
9.3.2.
Mexico Senolytic Drugs Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type
9.3.2.2.2.
By Application
9.3.2.2.3.
By Distribution Channel
9.3.3.
Canada Senolytic Drugs Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type
9.3.3.2.2.
By Application
9.3.3.2.3.
By Distribution Channel
10. Europe Senolytic
Drugs Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1. By Type
10.2.2. By Application
10.2.3. By Distribution Channel
10.2.4.
By Country
10.3.
Europe: Country Analysis
10.3.1.
France Senolytic Drugs Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Type
10.3.1.2.2.
By Application
10.3.1.2.3.
By Distribution Channel
10.3.2.
Germany Senolytic Drugs Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Type
10.3.2.2.2.
By Application
10.3.2.2.3.
By Distribution Channel
10.3.3.
United Kingdom Senolytic Drugs Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Type
10.3.3.2.2.
By Application
10.3.3.2.3.
By Distribution Channel
10.3.4.
Italy Senolytic Drugs Market Outlook
10.3.4.1.
Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2.
Market Share & Forecast
10.3.4.2.1.
By Type
10.3.4.2.2.
By Application
10.3.4.2.3.
By Distribution Channel
10.3.5.
Spain Senolytic Drugs Market Outlook
10.3.5.1.
Market Size & Forecast
10.3.5.1.1.
By Value
10.3.5.2.
Market Share & Forecast
10.3.5.2.1.
By Type
10.3.5.2.2.
By Application
10.3.5.2.3.
By Distribution Channel
11. Asia-Pacific
Senolytic Drugs Market Outlook
11.1.
Market Size & Forecast
11.1.1.
By Value
11.2.
Market Share & Forecast
11.2.1. By Type
11.2.2. By Application
11.2.3. By Distribution Channel
11.2.4.
By Country
11.3.
Asia-Pacific: Country Analysis
11.3.1.
China Senolytic Drugs Market Outlook
11.3.1.1.
Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2.
Market Share & Forecast
11.3.1.2.1.
By Type
11.3.1.2.2.
By Application
11.3.1.2.3.
By Distribution Channel
11.3.2.
India Senolytic Drugs Market Outlook
11.3.2.1.
Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2.
Market Share & Forecast
11.3.2.2.1.
By Type
11.3.2.2.2.
By Application
11.3.2.2.3.
By Distribution Channel
11.3.3.
South Korea Senolytic Drugs Market Outlook
11.3.3.1.
Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2.
Market Share & Forecast
11.3.3.2.1.
By Type
11.3.3.2.2.
By Application
11.3.3.2.3.
By Distribution Channel
11.3.4.
Japan Senolytic Drugs Market Outlook
11.3.4.1.
Market Size & Forecast
11.3.4.1.1.
By Value
11.3.4.2.
Market Share & Forecast
11.3.4.2.1.
By Type
11.3.4.2.2.
By Application
11.3.4.2.3.
By Distribution Channel
11.3.5.
Australia Senolytic Drugs Market Outlook
11.3.5.1.
Market Size & Forecast
11.3.5.1.1.
By Value
11.3.5.2.
Market Share & Forecast
11.3.5.2.1.
By Type
11.3.5.2.2.
By Application
11.3.5.2.3.
By Distribution Channel
12. South America
Senolytic Drugs Market Outlook
12.1.
Market Size & Forecast
12.1.1.
By Value
12.2.
Market Share & Forecast
12.2.1. By Type
12.2.2. By Application
12.2.3. By Distribution Channel
12.2.4.
By Country
12.3.
South America: Country Analysis
12.3.1.
Brazil Senolytic Drugs Market Outlook
12.3.1.1.
Market Size & Forecast
12.3.1.1.1.
By Value
12.3.1.2.
Market Share & Forecast
12.3.1.2.1.
By Type
12.3.1.2.2.
By Application
12.3.1.2.3.
By Distribution Channel
12.3.2.
Argentina Senolytic Drugs Market Outlook
12.3.2.1.
Market Size & Forecast
12.3.2.1.1.
By Value
12.3.2.2.
Market Share & Forecast
12.3.2.2.1.
By Type
12.3.2.2.2.
By Application
12.3.2.2.3.
By Distribution Channel
12.3.3.
Colombia Senolytic Drugs Market Outlook
12.3.3.1.
Market Size & Forecast
12.3.3.1.1.
By Value
12.3.3.2.
Market Share & Forecast
12.3.3.2.1.
By Type
12.3.3.2.2.
By Application
12.3.3.2.3.
By Distribution Channel
13. Middle East and
Africa Senolytic Drugs Market Outlook
13.1.
Market Size & Forecast
13.1.1.
By Value
13.2.
Market Share & Forecast
13.2.1. By Type
13.2.2. By Application
13.2.3. By Distribution Channel
13.2.4.
By Country
13.3.
MEA: Country Analysis
13.3.1.
South Africa Senolytic Drugs Market Outlook
13.3.1.1.
Market Size & Forecast
13.3.1.1.1.
By Value
13.3.1.2.
Market Share & Forecast
13.3.1.2.1.
By Type
13.3.1.2.2.
By Application
13.3.1.2.3.
By Distribution Channel
13.3.2.
Saudi Arabia Senolytic Drugs Market Outlook
13.3.2.1.
Market Size & Forecast
13.3.2.1.1.
By Value
13.3.2.2.
Market Share & Forecast
13.3.2.2.1.
By Type
13.3.2.2.2.
By Application
13.3.2.2.3.
By Distribution Channel
13.3.3.
UAE Senolytic Drugs Market Outlook
13.3.3.1.
Market Size & Forecast
13.3.3.1.1.
By Value
13.3.3.2.
Market Share & Forecast
13.3.3.2.1.
By Type
13.3.3.2.2.
By Application
13.3.3.2.3.
By Distribution Channel
14.
Market Dynamics
14.1.
Drivers
14.2.
Challenges
15.
Market Trends & Developments
16.
Competitive Landscape
16.1.
AgeX Therapeutics, Inc.
16.2.
Cleara Biotech
16.3.
Eternans Ltd.
16.4.
FoxBio Inc
16.5.
Numeric Biotech
16.6.
T.A. Sciences, Inc.
16.7.
Recursion Pharmaceuticals, Inc.
17.
Strategic
Recommendations
18. About Us &
Disclaimer